Johnson & Johnson

Like Bristol-Myers Squibb and AbbVie, Johnson & Johnson seeks to bolster neuropsychiatric portfolio with $15 billion… Benzinga10:10Intra-Cellular Therapies Pharma

Intra-Cellular Therapies stock is surging Monday: What's going on? Benzinga15:17Intra-Cellular Therapies Pharma

J&J to leverage Intra-Cellular Therapies’ neurology portfolio Pharmaceutical Technology12:02Intra-Cellular Therapies Biotechnology Pharma

J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition PMLiVE07:35Intra-Cellular Therapies Biotechnology Pharma

J&J talc group’s bid to hire big law firms prompts DOJ challenge Bloomberg Law16:13J&J Pharma

J&J talc unit objects to committee bid to hire Brown Rudnick Bloomberg Law14:13J&J Pharma

Intra-Cellular Therapies stock pops as Johnson & Johnson buys firm for $14.6B Investopedia09:42Alzheimer's Biotechnology Pharma

J&J files intravesical bladder cancer drug TAR-200 in US pharmaphorum06:17TAR-200 Business (US) Pharma

[JPM2025] J&J says Leclaza combo therapy’s potential is undervalued – and for good reason Korea Biomedical Review21:36Cancer Treatment JPMorgan Chase California Business

Aggressive protection of Stelara may indicate J&J’s immunology strategy Pharmaceutical Technology06:09Pharma AbbVie Biotech

Johnson & Johnson MedTech’s Dual Energy Catheter gains Ce mark approval Verdict Medical Devices04:45Energy and Utilities Pharma

FTSE 100 Live: Dashed rate cut hopes hit stocks; Oil weighs on airlines Proactive Investors (UK)06:00GSK FTSE 100 UK Stock Market

Johnson & Johnson MedTech pauses Varipulse rollout in US Verdict Medical Devices05:52Varipulse Pharma

Johnson & Johnson pauses US Varipulse procedures amid safety review, investigates brain-related events Benzinga12:55Varipulse Pharma

Latest News

In the last hour

Expert Witnesses Limited In J&J Talc Ch. 11 Dismissal Try Law36018:44

In the last 8 hours

J&J’s Combination Lung Cancer Treatment Adds a Year to Patient Survival HumanProgress11:42

Earlier today

Johnson & Johnson’s (JNJ) Undervalued Dividend Shines in an Overpriced Market TipRanks08:05

U.S. Cancer Biopsy Market and Competition Analysis, 2025-2030, Featuring Key Players - BD, IZI Medical Products,… GlobeNewswire (Press Release)06:23

J&J files intravesical bladder cancer drug TAR-200 in US pharmaphorum06:17

Yesterday

J&J Talc Group’s Bid to Hire Big Law Firms Prompts DOJ Challenge Bloomberg Law16:13 15-Jan-25

Critical Mass With Law.com's Amanda Bronstad: First Lawsuits Over Los Angeles Wildfires Name Edison, J&J Talc Trial in… Law.com15:38 15-Jan-25

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug… PR Newswire (Press Release)08:04 15-Jan-25

Aggressive protection of Stelara may indicate J&J’s immunology strategy Pharmaceutical Technology06:09 15-Jan-25

In the last 7 days

[JPM2025] J&J says Leclaza combo therapy’s potential is undervalued – and for good reason Korea Biomedical Review21:36 14-Jan-25

The Dallas Company That Could End an $8 Billion Johnson & Johnson Talc Powder Lawsuit D Magazine17:16 14-Jan-25

J&J’s Prime Rating at Risk Because of Intra-Cellular Acquisition Yahoo! UK & Ireland15:29 14-Jan-25

Pittsburgh Jury’s Attempt to Award $22 Million in Johnson & Johnson Talc Case Highlights Trial Complexities JD Supra14:59 14-Jan-25

See Which Of The Latest 13F Filers Holds Johnson & Johnson Nasdaq13:44 14-Jan-25

J&J to leverage Intra-Cellular Therapies’ neurology portfolio Pharmaceutical Technology12:02 14-Jan-25

In brief: International Biotechnology Trust notes investee sale to J&J London South East11:00 14-Jan-25

Trellus Health shares soar on collaboration with Johnson & Johnson London South East09:08 14-Jan-25

Oric Pharma Stock Climbs On Clinical Supply Deal With J&J's Janssen For Oric-114 RTT News07:49 14-Jan-25

J&J expands neuroscience capabilities with $14.6bn Intra-Cellular acquisition PMLiVE07:35 14-Jan-25

Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company PR Newswire (Press Release)07:05 14-Jan-25

Aim winners & losers: MyHealthChecked celebrates test kit registration London South East05:45 14-Jan-25

Trellus Health shares jump 180% on Johnson & Johnson collaboration Proactive Investors (UK)04:01 14-Jan-25

J&J To Buy Intra-Cellular, Psychiatric Drug Caplyta For $14.6bn Scrip Pharma Intelligence18:22 13-Jan-25

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal BioWorld17:31 13-Jan-25

What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies Seeking Alpha15:23 13-Jan-25

Intra-Cellular Therapies Stock Is Surging Monday: What's Going On? Benzinga15:17 13-Jan-25

Cravath-led J&J To Buy Neuropsychiatric Drug Co. For $14.6B Law36014:00 13-Jan-25

J&J to acquire psychiatric drugs maker Intra-Cellular for $14.6 billion The Economic Times13:07 13-Jan-25

J&J to Acquire Intra-Cellular for $14.6B Genetic Engineering and Biotechnology News12:15 13-Jan-25

Alzheimer's Drugs Market Report and Forecast 2024-2032, Competitive Analysis of F. Hoffmann-La Roche, Novartis, Merck… GlobeNewswire (Press Release)11:49 13-Jan-25

Cravath, Davis Polk Steer J&J’s $14.6 Billion Intra-Cellular Buy Bloomberg Law10:46 13-Jan-25

J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system… Yahoo! UK & Ireland10:36 13-Jan-25

JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B FiercePharma10:32 13-Jan-25

Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion… Benzinga10:10 13-Jan-25

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B Investopedia09:42 13-Jan-25

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the… GlobeNewswire (Press Release)08:20 13-Jan-25

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular… Business Wire (Press Release)08:14 13-Jan-25

J&J agrees $14.6bn takeover of CNS biotech Intra-Cellular pharmaphorum07:55 13-Jan-25

J&J to buy psychiatric drug developer Intra-Cellular for $14.6B BioPharma Dive07:45 13-Jan-25

Johnson & Johnson to buy Intra-Cellular Therapies for $14.6bn London South East07:43 13-Jan-25

Johnson & Johnson to bolster neuroscience portfolio with $14.6bn Intra-Cellular Therapies acquisition Manufacturing Chemist07:21 13-Jan-25

Johnson & Johnson in talks to acquire Intra-Cellular Therapies Pharmaceutical Technology07:04 13-Jan-25

J&J to Acquire Intra-Cellular for About $14.6 Billion (3) Bloomberg Law07:01 13-Jan-25

M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson TipRanks07:00 13-Jan-25

J&J to buy Intra-Cellular Therapies for $14.6 billion Yahoo! UK & Ireland06:43 13-Jan-25

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular… Business Wire (Press Release)06:31 13-Jan-25

2 Beaten-Down Dividend Stocks to Buy in 2025 The Motley Fool06:11 13-Jan-25

FTSE 100 Live: Dashed rate cut hopes hit stocks; Oil weighs on airlines Proactive Investors (UK)06:00 13-Jan-25

Johnson & Johnson MedTech’s Dual Energy Catheter gains CE mark approval Verdict Medical Devices04:45 13-Jan-25

Johnson & Johnson eyes $10bn acquisition of Intra-Cellular Therapies Proactive Investors (US)04:15 13-Jan-25

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to… PR Newswire (Press Release)03:02 13-Jan-25

J&J Is Said to Be in Talks to Acquire Intra-Cellular (1) Bloomberg Law01:21 13-Jan-25

Johnson & Johnson Could Serve As High-Yield Bond Alternative Seeking Alpha15:18 11-Jan-25

J&J Talc Claimants Seek Sanctions Over Morelli No-Show Law36016:25 10-Jan-25

Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter Johnson & Johnson (Press Release)08:08 10-Jan-25

The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision… PR Newswire (Press Release)07:06 10-Jan-25

J&J Spin-Off Says Talc Committee Can't Hire Brown Rudnick Law36019:13 9-Jan-25

J&J Talc Unit Objects to Committee Bid to Hire Brown Rudnick Bloomberg Law14:13 9-Jan-25

Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events Benzinga12:55 9-Jan-25

J&J Gets FDA Fast Track Designation for Alzheimer’s mAb, Posdinemab PharmTech.com08:04 9-Jan-25

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis (gMG) Johnson & Johnson (Press Release)08:01 9-Jan-25

Arkuda Therapeutics Announces Option Exercise and Asset Purchase PR Newswire (Press Release)07:07 9-Jan-25

Mendaera Appoints Medical Robotics Leader Eric Davidson as Chief Commercial Officer Business Wire (Press Release)07:02 9-Jan-25

Johnson & Johnson MedTech pauses Varipulse rollout in US Verdict Medical Devices05:52 9-Jan-25

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha02:03 9-Jan-25

In the last month

Ex-Marketing Exec Says J&J Unit Dodging Basic Discovery Law36016:03 8-Jan-25

J&J Halts Varipulse Pulsed-Field Ablation Cases in the US TCTMD14:50 8-Jan-25

Posdinemab Receives FDA Fast Track Designation for Treatment of Alzheimer Disease Pharmacy Times14:39 8-Jan-25

Dow Movers: JNJ, WMT Nasdaq12:32 8-Jan-25

Johnson & Johnson Statement on VARIPULSE™ U.S. External Evaluation Johnson & Johnson (Press Release)12:32 8-Jan-25

aBLA Updates: Stelara® Biosimilar Steqeyma™ (ustekinumab-stba) FDA-Approval; Lucentis® Biosimilar Xlucane™… JD Supra12:13 8-Jan-25

Johnson & Johnson stock reaches 52-week low as markets fall FXstreet11:48 8-Jan-25

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory… PR Newswire (Press Release)08:42 8-Jan-25

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track… PR Newswire (Press Release)08:01 8-Jan-25

Johnson & Johnson (NYSE:JNJ) Jumps to Year’s High on Lung Cancer Drug Success TipRanks06:01 8-Jan-25

J&J says Rybrevant combo has survival edge over Tagrisso pharmaphorum04:26 8-Jan-25

J&J, Talc Suppliers, Insurers Spar Over $505M Sale Stay Law36019:41 7-Jan-25

Johnson & Johnson: I'm Saying Yes To This Mess Seeking Alpha16:54 7-Jan-25

Noteworthy Tuesday Option Activity: SCHW, JNJ, HELE Nasdaq15:51 7-Jan-25

J&J lung cancer treatment extends lives versus AstraZeneca drug Proactive Investors (US)13:39 7-Jan-25

Ophthalmic Lasers Market Global Outlook & Forecast 2024-2029, with Key Vendor Profiles for… Business Wire (Press Release)11:28 7-Jan-25

J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care BNN Bloomberg08:41 7-Jan-25

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) shows statistically significant and clinically meaningful… Johnson & Johnson (Press Release)08:02 7-Jan-25

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show statistically significant and… PR Newswire (Press Release)08:02 7-Jan-25

Japan's Kaken Pharma enters into license agreement for STAT6 inhibitor with Johnson & Johnson for $1.2 B BioSpectrum Asia05:12 7-Jan-25

J&J expands atopic dermatitis pipeline with Kaken Pharmaceutical licensing deal PMLiVE07:14 6-Jan-25

J&J lifts profit and sales forecasts after beating expectations Financial Mail04:25 5-Jan-25

Court Reverses Denial of J&J’s Motion for Summary Judgment on Causation Grounds JD Supra14:39 3-Jan-25

Conventional and Alternative Pain Treatment Market Research 2024-2029, Profiles of Market… Business Wire (Press Release)08:26 3-Jan-25

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know Barchart04:53 3-Jan-25

Daily Dividend Report: WSO,JNJ,CMC,GFL,AFG Nasdaq13:11 2-Jan-25

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025 Business Wire (Press Release)08:03 2-Jan-25

J&J’s Rybrevant/Lazcluze combination approved by EC for EGFR-mutated lung cancer PMLiVE07:28 2-Jan-25

Johnson & Johnson hit with class action over medication that ‘doesn’t work’ Lawyers Weekly15:04 1-Jan-25

Devastated family say talcum powder linked to mum's cancer death Yahoo! UK & Ireland12:02 31-Dec-24

Devastated family sue Johnson & Johnson over talcum powder cancer claims Yahoo! UK & Ireland11:52 31-Dec-24

Oncology Pharmaceuticals Market Research 2024-2029, Profiles of Major Players - Bristol-Myers Squibb, Merck & Co, F.… GlobeNewswire (Press Release)04:06 31-Dec-24

Family of mother who claim she died from cancer caused by Johnson and Johnson talcum powder to… MailOnline09:38 30-Dec-24

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space BioWorld14:58 27-Dec-24

Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise Benzinga13:38 27-Dec-24

Man sues Johnson & Johnson for $25m claiming talcum powder killed wife The Independent12:45 27-Dec-24

FDA Proposes New Testing Rules to Ensure Cosmetics Are Asbestos-Free Medpage Today12:04 27-Dec-24

Dow Jones: Tech Weakness Drives 400-Point Drop Led by Microsoft, Apple, Nvidia FX Empire11:28 27-Dec-24

JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723 Zacks06:31 27-Dec-24

U.S. Food and Drug Administration proposes new testing rules to ensure cosmetics are asbestos-free The Hindu01:25 27-Dec-24

Man sues Johnson & Johnson for $25 million, says talc powder killed wife CBS Austin23:18 26-Dec-24

What's Next For Johnson & Johnson's Talcum Powder Litigation? Law.com12:26 26-Dec-24

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks08:38 26-Dec-24

Johnson & Johnson to license novel oral assets, further strengthening commitment to atopic dermatitis Johnson & Johnson (Press Release)08:02 26-Dec-24

The Smartest Dividend Stocks to Buy With $1,000 Right Now The Motley Fool05:43 26-Dec-24

Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks The Motley Fool05:42 24-Dec-24

Bankruptcy shouldn't keep Johnson & Johnson, other companies from being held accountable Chicago Sun-Times19:07 23-Dec-24

Noteworthy Monday Option Activity: ALB, JNJ, HELE Nasdaq15:53 23-Dec-24

Class action filed against Johnson & Johnson over 'ineffective' meds Radio New Zealand14:07 20-Dec-24

Aussie law firm sues pharma giant Johnson & Johnson over bombshell claims its cold and flu… MailOnline07:28 20-Dec-24

view more headlines

16 Jan 18:44

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.